Ann: MedAdvisor Appoints Chris Ridd as Non Executive Chair, page-2

Great appointment as Chair with tonnes of relevant experience in international SaaS companies.

If the share price can take the same trajectory as XRO when it listed (and during Chris’s tenure) I’ll be very happy.

Peter came from ERD (Exalt Resources), the vehicle MedAdvisor used to list. I’ve had the pleasure in speaking with him a couple times during the AGMs. As he’s been around since listing his new appointment of NED should be valuable. If he wanted out I’m sure he could have sold his holding and left company. I suspect he sees the future and wants to stay connected and invested.

Management are building a great network of people and ensuring expansion is managed. Hitting the accelerator too quickly can require maintenance down the track.

HY should be out next week. Numbers will again show growth but unfortunately nothing from international yet (as per the Dec quarter).

Perhaps MedAdvisor should release a Patient Engagement Program and partner with Schulke for a rebranded MDR sanitizer. Seems you just need to mention the word Coronavirus in an announcement and the share price jumps (*cough* FOD, ZNO, BIT)